Literature DB >> 1371164

The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.

M Urban1, W Britt, M Mach.   

Abstract

Bacterial fusion proteins, constructed from overlapping fragments of the open reading frame coding for gp86 of human cytomegalovirus (HCMV) strain AD169, were used to localize antigenic regions recognized by antibodies from human convalescent sera. A major domain for binding of conformation-independent antibodies was localized on fusion protein AP86, containing amino acids 15 to 142 of gp86. Human antibodies, affinity purified on AP86, neutralized infectious virus in tissue culture. In addition, a mouse monoclonal antibody (AP86-SA4), raised against AP86, also neutralized HCMV. AP86-SA4 was reactive with viral gp86 in immunoblot assays and showed a plasma membrane staining on intact HCMV-infected fibroblasts late in infection. After exonuclease III deletions of the viral gene, the binding site of neutralizing human as well as mouse antibodies was localized between amino acid residues 34 and 43. The domain has sequence variation between laboratory strains AD169 and Towne, and binding of the antibodies was strain specific. To our knowledge, this is the first characterization of a strain-specific neutralizing epitope on HCMV.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371164      PMCID: PMC240851     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Human cytomegalovirus: recent aspects from molecular biology.

Authors:  M Mach; T Stamminger; G Jahn
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

2.  Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.

Authors:  W J Britt; D Auger
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

3.  Characterization of glycoprotein complexes present in human cytomegalovirus envelopes.

Authors:  G H Farrar; P J Greenaway
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

4.  Further characterization of the fate of human monoclonal antibodies in rhesus monkeys.

Authors:  P H Ehrlich; Z A Moustafa; J C Justice; K E Harfeldt; L Ostberg
Journal:  Hybridoma       Date:  1988-08

5.  Characterization of a human cytomegalovirus glycoprotein complex (gcI).

Authors:  D R Gretch; R C Gehrz; M F Stinski
Journal:  J Gen Virol       Date:  1988-06       Impact factor: 3.891

6.  Characterization of monoclonal antibodies and polyclonal immune sera directed against human cytomegalovirus virion proteins.

Authors:  B Nowak; C Sullivan; P Sarnow; R Thomas; F Bricout; J C Nicolas; B Fleckenstein; A J Levine
Journal:  Virology       Date:  1984-01-30       Impact factor: 3.616

7.  Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting.

Authors:  M P Landini; M C Re; G Mirolo; B Baldassarri; M La Placa
Journal:  J Med Virol       Date:  1985-12       Impact factor: 2.327

8.  Cleavage of procaryotically expressed human immunodeficiency virus fusion proteins by factor Xa and application in western blot (immunoblot) assays.

Authors:  S Ellinger; R Glockshuber; G Jahn; A Plückthun
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

9.  Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.

Authors:  R S Haddad; L M Hutt-Fletcher
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H.

Authors:  M P Cranage; G L Smith; S E Bell; H Hart; C Brown; A T Bankier; P Tomlinson; B G Barrell; T C Minson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  41 in total

1.  Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells.

Authors:  Regan N Theiler; Teresa Compton
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

2.  Intrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees.

Authors:  Ravit Arav-Boger; Sallie R Permar; Cody S Nelson; Diana Vera Cruz; Melody Su; Guanhua Xie; Nathan Vandergrift; Robert F Pass; Michael Forman; Marie Diener-West; Katia Koelle
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

3.  The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Authors:  Lucy Rasmussen; Aimee Geissler; Catherine Cowan; Amanda Chase; Mark Winters
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116).

Authors:  W J Britt; L G Vugler
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  A novel real-time PCR method for determination and quantification of each cytomegalovirus glycoprotein H subtype in clinical samples.

Authors:  Kazufumi Ikuta; Ken Ishioka; Yuka Sato; Takashi Imamura; Kimisato Asano; Shin Koyano; Naoki Inoue; Tatsuo Suzutani
Journal:  J Clin Microbiol       Date:  2011-11-23       Impact factor: 5.948

6.  Enzyme-linked immunosorbent assay method for detection of cytomegalovirus strain-specific antibody responses.

Authors:  Zdenek Novak; Shannon A Ross; Raj Kumar Patro; Sunil Kumar Pati; Meera K Reddy; Misty Purser; William J Britt; Suresh B Boppana
Journal:  Clin Vaccine Immunol       Date:  2008-11-26

7.  Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.

Authors:  J A Simpson; J C Chow; J Baker; N Avdalovic; S Yuan; D Au; M S Co; M Vasquez; W J Britt; K L Coelingh
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

8.  Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.

Authors:  Xiaohong Cui; Daniel C Freed; Dai Wang; Ping Qiu; Fengsheng Li; Tong-Ming Fu; Lawrence M Kauvar; Michael A McVoy
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

9.  Coiled-coil domains in glycoproteins B and H are involved in human cytomegalovirus membrane fusion.

Authors:  Matthew Lopper; Teresa Compton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Scanning Mutagenesis of Human Cytomegalovirus Glycoprotein gH/gL.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Erin E Ellerbeck; Brent J Ryckman
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.